Skandinaviska Enskilda Banken (SEB)
PDLI

Skandinaviska Enskilda Banken (SEB)’s PDL BioPharma, Inc. PDLI Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-99,400
Closed -$312K – 955
2019
Q2 		$312K Sell
99,400
-610,400
-86% -$1.98M ﹤0.01% 757
2019
Q1 		$2.64M Sell
709,800
-59,600
-8% -$201K 0.02% 403
2018
Q4 		$2.23M Sell
769,400
-392,400
-34% -$1.08M 0.02% 445
2018
Q3 		$3.06M Buy
1,161,800
+240,100
+26% +$589K 0.02% 394
2018
Q2 		$2.16M Buy
921,700
+105,500
+13% +$295K 0.02% 416
2018
Q1 		$2.4M Sell
816,200
-41,800
-5% -$114K 0.02% 355
2017
Q4 		$2.35M Sell
858,000
-401,300
-32% -$1.23M 0.02% 407
2017
Q3 		$4.27M Buy
1,259,300
+88,400
+8% +$246K 0.04% 320
2017
Q2 		$2.89M Sell
1,170,900
-431,700
-27% -$993K 0.03% 392
2017
Q1 		$3.64M Sell
1,602,600
-94,400
-6% -$209K 0.04% 336
2016
Q4 		$3.6M Buy
1,697,000
+177,600
+12% +$496K 0.04% 287
2016
Q3 		$5.09M Buy
1,519,400
+156,000
+11% +$495K 0.06% 256
2016
Q2 		$4.28M Buy
1,363,400
+140,900
+12% +$470K 0.05% 278
2016
Q1 		$4.07M Sell
1,222,500
-331,900
-21% -$1.03M 0.05% 284
2015
Q4 		$5.5M Buy
+1,554,400
New +$6.51M 0.07% 201

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s PDLI Position: Q3 2019 in Review

Skandinaviska Enskilda Banken (SEB) sold out of PDL BioPharma, Inc. (PDLI) in Q3 2019, closing a stake of 99,400 shares — an estimated $312K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in PDLI in Q4 2015 and held it in 15 quarters. The position peaked at $5.5M in Q4 2015. 140 funds tracked by Wall St. Rank hold PDLI as of Q3 2019.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining PDL BioPharma, Inc. position as of Q3 2019 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 99,400 PDL BioPharma, Inc. shares in Q3 2019, an estimated $312K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in PDL BioPharma, Inc. in Q4 2015 and held it in 15 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s PDL BioPharma, Inc. position peaked at $5.5M in Q4 2015.
  • 140 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2019.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2019, filed 8 Nov 2019.